Adverse reactions : תופעות לוואי

4.8 Undesirable effects
The frequencies of adverse reactions are ranked according to the following : very common (> 1/10), common (> 1/100 to < 1/10); uncommon (>1/1000 to < 1/100); rare (>1/10,000 to < 1/1000); very rare (< 1/10,000) ; not known (cannot be estimated from the available data)
Immune system disorders:
Rare: hypersensitivity
Metabolism and nutrition disorders:
Uncommon: hyperglycaemia, gout
Nervous system disorders:
Uncommon: dizziness, dysgeusia, headache
Cardiac disorders:
Common: atrial fibrillation
Vascular disorders:
Uncommon: hypotension
Respiratory thoracic and mediastinal disorders:
Uncommon: epistaxis
Gastrointestinal disorders:
Common: gastrointestinal disorders (including abdominal distension, abdominal pain, constipation, diarrhoea, dyspepsia, flatulence, eructation, gastro-oesophageal reflux disease, nausea or vomiting)
Uncommon: gastrointestinal haemorrhage
Hepatobiliary disorders:
Rare: liver disorders (including transaminases increased, alanine aminotransferase increased and aspartate aminotransferase increased)
Skin and subcutaneous tissue disorders:
Uncommon: rash
Rare: urticaria
Not known: pruritus
Reporting of suspected adverse reactions
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form.
https://sideeffects.health.gov.il/